To the best of our knowledge, we are the first to knockdown MMP-2/MMP-9 in RB cell in vitro stably by shRNA gene silencing technique, which was different from the study of Webb et al. in 2017 [13]. The gene discussed is MMP2; the disease is retinoblastoma.